abnormal pancreatic beta cell physiology, abnormal pancreatic islet cell apoptosis, abnormal pancreatic islet morphology, abnormal placental labyrinth vasculature morphology, abnormal vascular development, abnormal vitelline vasculature morphology, decreased erythrocyte cell number, decreased fat cell size, decreased fetal size, decreased insulin secretion, decreased liver weight, decreased total fat pad weight, enhanced coordination, growth/size/body region phenotype, hematopoietic system phenotype, homeostasis/metabolism phenotype, impaired ability to fire action potentials, increased anti-insulin autoantibody level, increased circulating C-reactive protein level, increased circulating interleukin-1 beta level, increased circulating interleukin-6 level, increased circulating ketone body level, increased circulating tumor necrosis factor level, increased fluid intake, increased pancreatic beta cell apoptosis, increased susceptibility to autoimmune diabetes, lethality throughout fetal growth and development, complete penetrance, lethality throughout fetal growth and development, incomplete penetrance, pale liver, postnatal lethality, complete penetrance, prenatal lethality, prenatal lethality, complete penetrance, small liver